Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-wxhwt Total loading time: 0 Render date: 2024-07-11T19:17:46.054Z Has data issue: false hasContentIssue false

9 - Lupus and connective tissue disease in pregnancy

from SECTION 3 - CHRONIC KIDNEY DISEASE

Published online by Cambridge University Press:  05 September 2014

Mike Venning
Affiliation:
Manchester Royal Infirmary
Mumtaz Patel
Affiliation:
Manchester Royal Infirmary
John Davison
Affiliation:
University of Newcastle
Catherine Nelson-Piercy
Affiliation:
St Thomas’s Hospital, London
Sean Kehoe
Affiliation:
John Radcliffe Hospital, Oxford
Philip Baker
Affiliation:
University of Alberta
Get access

Summary

There is an increasing understanding of the impact of the presence of lupus nephritis on pregnancy outcome. Until recently, relatively little was known about pregnancy in vasculitic diseases, which are less common in women of childbearing age. These include the primary systemic vasculitides with potential for renal involvement: small vessel vasculitides including Wegener's granulomatosis, microscopic polyangiitis, Henoch-Schönlein purpura and Churg—Strauss syndrome. Also included are the medium-large vessel vasculitides such as Churg—Strauss syndrome (which may involve small and medium vessels), polyarteritis nodosa and Takayasu's arteritis. Primary systemic vasculitis is now classified as antineutrophil cytoplasmic antibody (ANCA)-positive (typically Wegener's granulomatosis or microscopic polyangiitis) or ANCA-negative vasculitis, which may blur the distinctions between the classically defined disorders. In this chapter the traditional diagnostic terms are retained, as many believe these relate to typically distinct disease entities and these terms are used in the great majority of publications concerning pregnancy.

The issues relating to lupus nephritis and vasculitis are discussed, but a review of associated autoantibodies such as antiphospholipid antibodies and the anti-Ro (SSA) and anti-La (SSB) is not included. These autoantibodies need to be screened for and managed according to the separate role they may play. In particular, attention will need to be paid to antiphospholipid syndrome and the neonatal lupus syndromes.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×